Symptom-Level Comorbidity of Fibromyalgia and Depression: A Network Approach within a Large Clinical Sample

Area of Science:

• Neuroscience
• Psychiatry
• Rheumatology

Background:

• Fibromyalgia syndrome (FMS) and major depressive disorder (MDD) frequently co-occur, but the underlying mechanisms are not well understood.
• Understanding the connections between FMS and MDD is crucial for developing effective treatment strategies.

Purpose of the Study:

• To identify symptom clusters within the FMS-MDD network.
• To pinpoint bridging symptoms that connect these clusters.
• To evaluate the role of pain severity in linking FMS and MDD.

Main Methods:

• Analysis of cross-sectional data from 3,044 FMS patients.
• Utilized a mixed graphical model to analyze 30 selected symptom nodes from an initial pool of 238 items.

Main Results:

• Identified seven distinct symptom clusters, including pain, autonomic, trauma/anxiety, sexual/health, anhedonia, cognitive-affective, and sleep/energy/social functioning.
• Depressed Mood, Fatigue, and Anxiety & Nervousness emerged as key bridging symptoms.
• Pain Severity showed minimal connectivity, primarily linking to sleep problems and fatigue.

Conclusions:

• Emotional and fatigue symptoms are more central in linking FMS and MDD than pain severity alone.
• Bridge symptoms like Fatigue and Depressed Mood represent potential targets for interventions.
• Further longitudinal studies are required to establish causality and evaluate treatment efficacy.